top
Search terms
Results 1 - 10 of 121 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 13
Ehjacc

Aims: To evaluate the impact of bivalirudin versus heparin on efficacy and safety outcomes of ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary ...

European Heart Journal: Acute Cardiovascular Care, Original scientific papers, Davide Capodanno, Giuseppe Gargiulo, Piera Capranzano, Roxana Mehran, Corrado Tamburino, Gregg W Stone

Date : 01/06/2016
Ehjacc

Aims: To evaluate the impact of bivalirudin versus heparin on efficacy and safety outcomes of ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary ...

European Heart Journal: Acute Cardiovascular Care, Original scientific papers, Davide Capodanno, Giuseppe Gargiulo, Piera Capranzano, Roxana Mehran, Corrado Tamburino, Gregg W Stone

Date : 01/06/2016
Ehjacc

Aims: To evaluate the impact of bivalirudin versus heparin on efficacy and safety outcomes of ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary ...

European Heart Journal: Acute Cardiovascular Care, Original scientific papers, Davide Capodanno, Giuseppe Gargiulo, Piera Capranzano, Roxana Mehran, Corrado Tamburino, Gregg W Stone

Date : 01/06/2016
Ehjacc

Aims: To evaluate the impact of bivalirudin versus heparin on efficacy and safety outcomes of ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary ...

European Heart Journal: Acute Cardiovascular Care, Original scientific papers, Davide Capodanno, Giuseppe Gargiulo, Piera Capranzano, Roxana Mehran, Corrado Tamburino, Gregg W Stone

Date : 01/06/2016
Ehjqcco

Evidence from recent trials, embedded into the latest clinical guidelines,1 has led to fierce debates about the role of revascularization on prognosis in coronary artery disease. [...]there are ...

European Heart Journal - Quality of Care and Clinical Outcomes, EDITORIALS, Mark A. de Belder

Date : 01/01/2016 Item size : 167105 bytes
AnatolianJournal

Meta-analysis of 16 randomized trials Ýbrahim Halil Tanboða1, Selim Topçu1, Enbiya Aksakal1, Mustafa Kurt2, Ahmet Kaya3, Vecih Oduncu4, Serdar Sevimli1 1Department of Cardiology, Faculty of ...

Date : 12/01/2017 Item size : 43522 bytes
Ehjournal

Discontinuation of antithrombotic drugs and, more particularly, dual antiplatelet therapy in this context can also have catastrophic consequences, with a risk of recurrence of thrombotic events and ...

European Heart Journal, Editorial, Jean-Pierre Bassand

Date : 01/10/2014
Ehjournal

Non-specific protein and cellular binding of UFH results in variable biological activity and can result in heparin-induced thrombocytopenia and thrombosis. [...]UFH binds to the glycoprotein ...

European Heart Journal, Editorial, Gregg W. Stone

Date : 07/09/2014
Ehjqcco

During this prolonged cooling-off period, patients were exposed to a risk of reinfarction or cardiac instability requiring emergent percutaneous or surgical revascularization.2 To provide some ...

European Heart Journal - Quality of Care and Clinical Outcomes, EDITORIALS, Jubin P. Joseph, Simon R. Redwood

Date : 01/01/2017
Ehjournal

With numerous trials across populations of patients with known vascular disease (secondary prevention) and those at risk of events (primary prevention), statins have been seen to reduce CV (and in ...

European Heart Journal, Editorial, Christopher P. Cannon

Date : 07/01/2016